Zimbabwe grants 37 licenses for medical cannabis
Zimbabwe legalized the use, cultivation, production and export of medical cannabis in April 2018. Besieged by applications, the government had temporarily suspended the granting of licenses. The process has been resumed since recently awarded 37 licenses, from over 200 applications, to local and foreign investors.
A production economy
«In recent months, more than 200 local and foreign companies have shown an interest in medical cannabis production. The cabinet has approved about 37 of them who will receive the necessary licenses. We are currently in the process of registering them,» explains Vangelis Haritatos, Deputy Minister of Agriculture, Land, Water, Climate and Rural Resettlement, at the 6th African Round Table forum in Victoria Falls.
Selected investors will receive a $50,000 license, valid for one year but renewable. Originally, licenses were to last five years and cost between $5,000 and $20,000. It would appear that, given the success of the initiative, the government has revised its plan to maximize profits. In fact, it makes no secret of the fact that this is first and foremost an economic opportunity.
Indeed, the country is an attractive destination for foreign companies wishing to produce at low cost and then distribute their output in more attractive markets. At the same time, no information on the local medical cannabis program is available. No local or foreign newspapers mention, for example, the conditions of access to medical cannabis for patients or any training for healthcare professionals.
Zimbabwe is the second African country to legalize the production of medical cannabis, after Lesotho which granted its first production licenses in September 2018. In this small landlocked state in South Africa, ravaged by AIDS and poverty, the picture is the same: cannabis is seen as a financial windfall boosting the local economy and agriculture.
In South Africa, on the other hand, citizens' demands for the right to consume have been heard, as the country's highest court ruled in September 2018 that. the private consumption of cannabis by adults was a constitutional right.
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
-
Cannabis in France2 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login